Pfizer
PFE
2,508 hedge funds and large institutions have $140B invested in Pfizer in 2020 Q3 according to their latest regulatory filings, with 179 funds opening new positions, 1,157 increasing their positions, 943 reducing their positions, and 88 closing their positions.
103% more first-time investments, than exits
New positions opened: 179 | Existing positions closed: 88
23% more repeat investments, than reductions
Existing positions increased: 1,157 | Existing positions reduced: 943
16% more funds holding in top 10
Funds holding in top 10: 89 → 103 (+14)
15% more call options, than puts
Call options by funds: $2.11B | Put options by funds: $1.83B
9% more capital invested
Capital invested by funds: $129B → $140B (+$11.3B)
3% more funds holding
Funds holding: 2,441 → 2,508 (+67)
2.16% less ownership
Funds ownership: 74.82% → 72.65% (-2.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$545M |
| 2 |
Barclays
London,
United Kingdom
|
+$216M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$146M |
| 4 |
Berkshire Hathaway
Omaha,
Nebraska
|
+$137M |
| 5 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
+$132M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$595M |
| 2 |
Goldman Sachs
New York
|
-$587M |
| 3 |
BlackRock
New York
|
-$472M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
-$410M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$396M |
PFE Hedge Fund Activity: Q3 2020 in Review
2,508 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2020, worth a combined $140B — up 8.7% from $129B a quarter earlier.
Buyers outnumbered sellers: 179 funds opened new PFE positions and 88 closed out — a net gain of 91 holders — while 1,157 added to existing stakes and 943 trimmed.
The largest buyer was Capital World Investors, adding an estimated $545M. The largest seller was Wellington Management Group, cutting an estimated $595M.
- 2,508 institutional investors held Pfizer (PFE) as of Q3 2020, up from 2,441 in Q2 2020.
- Funds reported $140B of Pfizer stock for Q3 2020, up 8.7% quarter-over-quarter.
- 179 funds opened new Pfizer positions in Q3 2020 and 88 closed out, a net change of +91 holders.
- The largest Pfizer buyer in Q3 2020 was Capital World Investors, an estimated $545M added.
- The largest Pfizer seller in Q3 2020 was Wellington Management Group, an estimated $595M sold.
Based on aggregated 13F filings for Q3 2020.